Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

19 juin 2017 08h00 HE | Source: Ammonett Pharma LLC

Ammonett Pharma Granted Orphan Drug Designation From the U.S. FDA for Ibutamoren Mesylate (MK-0677) for Treatment of Growth Hormone Deficiency

MIDLOTHIAN, Va., June 19, 2017 (GLOBE NEWSWIRE) -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill...
25 mai 2017 08h00 HE | Source: Ammonett Pharma LLC

Ammonett Pharma Receives Notice of Allowance of U.S. Patent for Oratrope™ Related to Detecting and Treating Growth Hormone Deficiency

MIDLOTHIAN, Va., May 25, 2017 (GLOBE NEWSWIRE) -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill...
23 mai 2017 08h00 HE | Source: Ammonett Pharma LLC

Ammonett Pharma Receives Positive Opinion from European Orphan Medicinal Products Committee for MK-0677 for Treatment of Pediatric Growth Hormone Deficiency

MIDLOTHIAN, Va., May 23, 2017 (GLOBE NEWSWIRE) -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill...